The EGFR pathway may also play an important role in oestrogen-independent breast cancer, and one group has presented preclinical data suggesting that hormone independent cells are more sensitive to EGFR TKIs than wild-type cells (Gee et al, 2001). The gene discussed is EGFR; the disease is breast cancer.